Food as a Therapeutic Agent, Antagonist, and Enabler of Pharmacotherapy: A Clinical and Mechanistic Review

Abstract Food intake is usually addressed in pharmacotherapy as a dosing condition or a source of food–drug interactions, yet this view treats food largely as a passive background exposure. To address the separation between therapeutic nutrition and food–drug interaction management, this narrative review proposes a clinically applicable role-based framework that classifies food as a therapeutic agent, an antagonist of pharmacotherapy, or an enabler of treatment according to the dietary exposure, drug and formulation, disease state, timing, and clinical intent. In this framework, food may function as a therapeutic agent, an antagonist of pharmacotherapy, or an enabler of treatment, depending not on the food itself but on the clinical context in which it is consumed. Therapeutic roles include dietary patterns, medically tailored meals, nutrients, and food-derived bioactive compounds that support disease control, symptom relief, nutritional rehabilitation, or treatment responsiveness. Antagonistic roles occur when food reduces efficacy, increases toxicity, or destabilizes response through altered absorption, metabolism, transport, pharmacodynamics, adherence, or food-access constraints. Enabling roles occur when meal timing, composition, or nutritional support increases or stabilizes drug exposure (exposure enablement), reduces gastrointestinal or other treatment-related adverse effects (tolerability enablement), or improves adherence and dosing feasibility (adherence/feasibility enablement). Mechanisms include gastrointestinal physiology, formulation behavior, enzyme and transporter activity, nutrient–drug pharmacodynamics, microbiome effects, and artificial nutrition. Applying this framework requires structured dietary assessment, explicit prescribing instructions, diet-sensitive medication review, and interprofessional care. By classifying food roles conditionally rather than assigning fixed properties to foods, this framework can support more precise prescribing, safer food–drug management, food/formulation design, and patient-centered care.

Authors

Publication Details

Journal
Food Science and Human Wellness
Published
2026-09-30
DOI
https://doi.org/10.26599/fshw.2026.9251254
Primary Topic
Diet and metabolism studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Food as a Therapeutic Agent, Antagonist, and Enabler of Pharmacotherapy: A Clinical and Mechanistic Review

Shikang Chen, Zhenhua Liang, Hazem Golshany, Wenyi Kang
Food Science and Human Wellness
Diet and metabolism studies
article

Food as a Therapeutic Agent, Antagonist, and Enabler of Pharmacotherapy: A Clinical and Mechanistic Review

Shikang Chen, Zhenhua Liang, Hazem Golshany, Wenyi Kang
article en

Abstract

Abstract Food intake is usually addressed in pharmacotherapy as a dosing condition or a source of food–drug interactions, yet this view treats food largely as a passive background exposure. To address the separation between therapeutic nutrition and food–drug interaction management, this narrative review proposes a clinically applicable role-based framework that classifies food as a therapeutic agent, an antagonist of pharmacotherapy, or an enabler of treatment according to the dietary exposure, drug and formulation, disease state, timing, and clinical intent. In this framework, food may function as a therapeutic agent, an antagonist of pharmacotherapy, or an enabler of treatment, depending not on the food itself but on the clinical context in which it is consumed. Therapeutic roles include dietary patterns, medically tailored meals, nutrients, and food-derived bioactive compounds that support disease control, symptom relief, nutritional rehabilitation, or treatment responsiveness. Antagonistic roles occur when food reduces efficacy, increases toxicity, or destabilizes response through altered absorption, metabolism, transport, pharmacodynamics, adherence, or food-access constraints. Enabling roles occur when meal timing, composition, or nutritional support increases or stabilizes drug exposure (exposure enablement), reduces gastrointestinal or other treatment-related adverse effects (tolerability enablement), or improves adherence and dosing feasibility (adherence/feasibility enablement). Mechanisms include gastrointestinal physiology, formulation behavior, enzyme and transporter activity, nutrient–drug pharmacodynamics, microbiome effects, and artificial nutrition. Applying this framework requires structured dietary assessment, explicit prescribing instructions, diet-sensitive medication review, and interprofessional care. By classifying food roles conditionally rather than assigning fixed properties to foods, this framework can support more precise prescribing, safer food–drug management, food/formulation design, and patient-centered care.

Food Science and Human Wellness
Zero hunger
Openalex Percentile: Top 12%
Diet and metabolism studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Food as a Therapeutic Agent, Antagonist, and Enabler of Pharmacotherapy: A Clinical and Mechanistic Review — Shikang Chen, Zhenhua Liang, et al. · Food Science and Human Wellness (2026) | TGRS Research Map | TGRS